2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 83.063 | 79.064 | 85.346 | 95.574 | 93.377 | 113.608 | 117.265 | 151.922 | 155.293 | 173.010 |
Total Income - EUR | 83.655 | 81.233 | 86.408 | 96.686 | 99.445 | 113.723 | 117.367 | 154.426 | 162.337 | 176.112 |
Total Expenses - EUR | 73.016 | 79.334 | 81.663 | 80.116 | 91.050 | 88.647 | 116.853 | 105.674 | 126.721 | 127.128 |
Gross Profit/Loss - EUR | 10.639 | 1.899 | 4.745 | 16.570 | 8.395 | 25.076 | 514 | 48.753 | 35.616 | 48.983 |
Net Profit/Loss - EUR | 7.639 | 298 | 3.881 | 14.550 | 7.401 | 24.076 | -113 | 47.553 | 34.362 | 47.618 |
Employees | 4 | 4 | 5 | 4 | 3 | 3 | 3 | 5 | 4 | 5 |
Check the financial reports for the company - Amamed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 26.806 | 40.065 | 33.693 | 42.417 | 44.427 | 32.630 | 25.467 | 47.919 | 76.128 | 73.984 |
Current Assets | 22.584 | 12.648 | 12.224 | 19.188 | 19.643 | 20.044 | 22.731 | 49.741 | 57.341 | 29.509 |
Inventories | 1.312 | 2.681 | 732 | 1.722 | 2.634 | 1.878 | 3.426 | 5.093 | 10.672 | 7.662 |
Receivables | 12.240 | 7.970 | 7.747 | 13.227 | 9.732 | 9.992 | 12.043 | 17.606 | 36.824 | 12.977 |
Cash | 9.032 | 1.998 | 3.745 | 4.239 | 7.277 | 8.174 | 7.262 | 27.043 | 9.846 | 8.870 |
Shareholders Funds | 44.854 | 32.515 | 14.185 | 28.495 | 35.373 | 34.361 | 26.415 | 55.302 | 42.134 | 53.605 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 4.864 | 20.808 | 31.732 | 33.109 | 28.697 | 18.313 | 21.115 | 39.841 | 87.939 | 48.794 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 668 | 2.518 | 3.396 | 1.329 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Amamed Srl